Alan Lazarus

Alan J. Lazarus is a partner and former vice chair of the firm’s Products Liability and Mass Tort Practice Group.

Products Liability and Toxic Tort Matters. Alan is an experienced trial and appellate attorney who specializes in products liability, toxic substances and environmental litigation. He also has experience handling commercial litigation, insurance coverage litigation and litigation arising from professional errors and omissions.

Alan has defended clients in wide variety of matters involving prescription and over-the-counter drugs, medical devices, vehicles, chemical exposures, asbestos exposures, nutritional supplements, homeopathic remedies, construction equipment, firearms and environmental contamination. He has appeared as lead counsel in multidistrict Litigation and statewide coordinated proceedings, and has defended nationwide and statewide class actions.

In General. Alan writes and lectures frequently on products liability and appellate practice topics. From 1992 to 1999, he was co-author and the editor of “Products, General Liability and Consumer Law: Annual Survey of Recent Developments” which appeared annually in the Tort & Insurance Law Journal. In 1996-1997, he served as the Defense Research Institute’s liaison to the American Law Institute project formulating the Third Restatement of Torts: Products Liability. He has been recognized as a California “Super Lawyer” annually since 2004.

A former law clerk to the late Hon. Cecil F. Poole of the United States Court of Appeals for the Ninth Circuit, Alan is certified by the State Bar of California Board of Legal Specialization as a Certified Specialist in Appellate Law. He is also a trained mediator and panelist on the First District Court of Appeal’s appellate mediation program.

Alan has also served as a member of the Emerging Issues Committee of the American Bar Association Section of Tort and Insurance Practice, and is the former chair of the Products, General Liability and Consumer Law committee of the Tort and Insurance Practice Section. He is an active member of the Defense Research Institute and the Product Liability Advisory Council, and participates in the latter organization’s amicus program.



From the Blog

Privately Held Medical Device and Drug Companies Face Unique Sunshine Act Challenges

As widely reported, the Centers for Medicare and Medicaid Services (“CMS”) recently issued regulations implementing the Sunshine Act provisions of the Affordable Care Act. ...

What Goes Up…Must Come Down: Viagra patent invalidated by Canadian Supreme Court

Pfizer and Teva have been fighting a legal battle over Pfizer’s patent for Viagra in Canada.  The first shot was fired when Novopharm Limited,...

The Perils and Promise of 3D Printing: Are DIY Life Sciences in Your Future?

With news that 3D printing (without question one of the coolest technologies to come down the road in quite some time) can be used...